A study of inter-alpha-trypsin inhibitor chains expression in liposarcomas

被引:2
|
作者
Tabata, I
Nishida, Y
Sugiura, H
Zhuo, L
Yoneda, M
Kimata, K
Nakashima, H
Ishiguro, N
机构
[1] Nagoya Univ, Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 4668550, Japan
[2] Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 48011, Japan
[3] Aichi Prefectural Coll Nursing & Hlth, Biochem & Mol Biol Lab, Moriyama Ku, Nagoya, Aichi, Japan
来源
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | 2003年 / 29卷 / 08期
关键词
inter-alpha-trypsin inhibitor; heavy chain; liposarcoma; prognosis;
D O I
10.1016/S0748-7983(03)00135-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: Liposarcoma is common soft tissue sarcoma that is sometimes difficult to treat, besides its good prognosis. The inter-alpha-trypsin inhibitor heavy chains (HCs) has been reported to be linked to hyaluronan, which play important roles in tumour progression and metastasis. In this study, clinical significance of HCs in patients with liposarcoma was investigated. Methods: HC expression was studied by immunohistochemistry on resected specimens of 33 liposarcoma patients and 10 lipoma patients. The expression of HC mRNA was analyzed by reverse transcription polymerase chain reaction (RT-PCR). Serum concentration of HC was determined with enzyme-linked immunosorbent assay (ELISA). Results: Prominent positive staining of HC was observed in extracellular matrix of pleomorphic and myxoid liposarcoma. In well-differentiated liposarcoma and lipoma, faint staining was seen with HC. No products of HC could be detected by RT-PCR. Serum concentration of HC was not up-regulated in any subtypes of liposarcoma. HC expression was not significantly correlated with tumour subtypes and prognosis. Conclusion: HC was strongly accumulated in pleomorphic and myxoid liposarcoma, however, was not locally synthesized in liposarcoma. HC might play roles in stabilizing extracellular matrix, such as hyaluronan (HA), in liposarcoma. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:665 / 669
页数:5
相关论文
共 50 条
  • [21] INTER-ALPHA-TRYPSIN INHIBITOR AND ITS DERIVATIVES IN INFLAMMATORY SYNDROMES
    LIONY, C
    SESBUE, R
    MANCHON, ND
    BERCOFF, E
    DELZANT, G
    MARTIN, JP
    BOURREILLE, J
    PRESSE MEDICALE, 1991, 20 (05): : 203 - 206
  • [22] ANTIGENIC RELATIONSHIP BETWEEN URINARY TRYPSIN-INHIBITOR AND PLASMA INTER-ALPHA-TRYPSIN INHIBITOR
    PROKSCH, GJ
    ROUTH, JI
    NORDSCHO.CD
    FEDERATION PROCEEDINGS, 1972, 31 (02) : A261 - &
  • [23] INTER-ALPHA-TRYPSIN INHIBITOR AND PRE-ALPHA-TRYPSIN INHIBITOR IN HEALTH AND DISEASE - DETERMINATION BY IMMUNOELECTROPHORESIS AND IMMUNOBLOTTING
    ODUM, L
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1990, 371 (12): : 1153 - 1158
  • [24] GENOMIC CLONING OF THE PROTEINASE-INHIBITOR SUBUNIT OF INTER-ALPHA-TRYPSIN INHIBITOR
    VETR, H
    KOGLER, M
    GEBHARD, W
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1988, 369 (09): : 936 - 937
  • [25] INTER-ALPHA-TRYPSIN INHIBITOR - INHIBITION SPECTRUM OF NATIVE AND DERIVED FORMS
    POTEMPA, J
    KWON, K
    CHAWLA, R
    TRAVIS, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (25) : 15109 - 15114
  • [26] INTER-ALPHA-TRYPSIN INHIBITOR IS A COMPLEX OF 3 DIFFERENT PROTEIN SPECIES
    GEBHARD, W
    LEYSATH, G
    SCHREITMULLER, T
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1988, 369 (05): : 19 - 22
  • [28] PLASMA-PROTEINS IMMUNOLOGICALLY RELATED TO INTER-ALPHA-TRYPSIN INHIBITOR
    LAROUI, S
    BALDUYCK, M
    MIZON, C
    SELLOUM, L
    MIZON, J
    BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 953 (03) : 263 - 268
  • [29] Dysregulated wound healing in inter-alpha-trypsin inhibitor deficient mice
    Trempus, C. S.
    Flake, G. P.
    Kissling, G. E.
    Stober, V.
    Zhuo, L.
    Kimata, K.
    Garantziotis, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S137 - S137
  • [30] A HINDIII RFLP AT THE PORCINE INTER-ALPHA-TRYPSIN INHIBITOR LOCUS (ITIH)
    COUPERWHITE, S
    BUCHMAN, TG
    ARCHIBALD, AL
    ANIMAL GENETICS, 1995, 26 (02) : 134 - 134